|
Health Sciences Center University of Utah |
Prestwich Research Group | ||||||
|
|||||||
|
Glenn D. Prestwich, Ph.D.
Department of Medicinal Chemistry University of Utah 419 Wakara Way, Suite 205 Salt Lake City, Utah 84108-1257 phone: 801-585-9051 fax: 801-585-9053 gprestwich@pharm.utah.edu
|
Research: Phosphoinositides/Phospholipids Phosphoinositides!-->!-->!-->!-->!-->!-->Visualizing Phospholipid (PL) and Phosphoinositide (PtdInsPn) and Signaling in Cells. Cell signaling via
lipids such as phosphoinositides (PIPs) and lysophosphatidic acid (LPA) are
accomplished by ligand activation of GPCRs, ligand-mediated protein
recruitment, and protein-catalyzed lipid remodeling by phospholipases,
phosphatases, and kinases. This talk with cover novel probes for cell biology
based on chemically-synthesized PIP and LPA analogs. First, for the PIPs, two novel chemical architectures, polymerized PIP-containing liposomes
and two-headed hybrid PIP-phospholipids, offer significant advantages for
interrogation of cellular lipid signaling. We describe the preparation and uses
of metabolically-stabilized PIPs, in which phosphonates and other
functionalities are selectively introduced to resist kinase, phosphatase, and
phospholipase cleavage. Second, for LPA, we have developed synthetic
routes for the preparation of long-lived receptor-specific agonists and
antagonists that are selective for LPA GPCRs isoforms. Other ligands act as
inhibitors of lysoPLD and lipid phosphate phosphatase (LPP). Furthermore,
fluorogenic substrates to provide real-time data on head-group selective
phospholipase A and D activities in cells have been developed. Examples of the
use of specific new probes in biological systems will be presented. Publications ListsUniversity of Utah Health Sciences Center 50 North Medical Drive, Salt Lake City, Utah 84132 HSC Webmaster Disclaimer | Privacy Statement |